Perindopril erbumine

This classification denotes an ace inhibitor with the molecular formula C19H32N2O5.C4H11N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1964X464OJ, chemically known as 1h-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-, (2s-(1(r*(r*)),2alpha,3abeta,7abeta))-, compd. with 2-methyl-2-propanamine (1:1) but more generally known as perindopril erbumine, which bears US NIH Compound Identifier 60183. European Medicines Agency schedules Perindopril erbumine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03711MIG. Most nations, for tariff and trade purposes, schedule perindopril erbumine under HS 29339990 and SITC 51577. As of Q4 2014, PERINDOPRIL ERBUMINE remains US FDA's Preferred Term for this commodity. Perindopril erbumine bears US NLM identifiers UMLS ID C0244718 and NCI Concept Code C47666. SMILES: CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O.CC(C)(C)N.